Latest News and Press Releases

Houston, TX, Jan. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) founding Director and Chief Executive Officer, Alex Blankenship,...

Houston, TX, Jan. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN). I have worked in the Intensive care unit as well as the cardiac unit, body builder and single mom with...

HOUSTON, TX, Jan. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced development of Full Salute™, a male ED (erectile...

Houston, TX, Dec. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced reacquisition and cancellation of 100% of the Company's...

Houston, TX, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”) today announced that holders of the Company's 12% unsecured convertible...

Houston, Texas, Oct. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) is pleased to announce the Company has executed a Settlement Agreement of the litigation with David...

Houston, TX , Aug. 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN) announced today the Company has filed an amendment to its Form 10-K for the fiscal year ended...

HOUSTON, TX, April 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements, is pleased to announce a one-year advertising contract...

HOUSTON, TX, April 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. (OTC: SOAN), a leading developer of dietary supplements and biotechnology research and development company, is...

HOUSTON, TEXAS, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – AngioSoma, Inc. (OTC: SOAN) is concerned that economic costs of diabetes in the USA were $327 BILLION in 2017, as reported by...